Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

297
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
297
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

270
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
270
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

316
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
316
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

238
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
238

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-term eculizumab treatment failure in C3 glomerulonephritis: two case reports.

Clinical kidney journal·2026
Same author

Pivotal Clinical Trials in C3 Glomerulopathy: answers and remaining uncertainties.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same author

Contactin-1 Membranous Nephropathy Without Neuropathy and Serum Antibodies.

Kidney international reports·2026
Same author

C3 Glomerulopathy: recent advances and an update on management.

Jornal brasileiro de nefrologia·2026
Same author

'…completely exhausted and weak, really drained.': a multinational qualitative interview study of healthcare provider, patient, and caregiver experiences of C3 glomerulopathy and primary (idiopathic) immune complex membranoproliferative glomerulonephritis diagnosis, burden and management.

Frontiers in nephrology·2026
Same author

Obinutuzumab or Tacrolimus in Primary Membranous Nephropathy.

The New England journal of medicine·2026

Related Experiment Video

Updated: Jan 6, 2026

Murine Bilateral Renal Lymphadenectomy
06:20

Murine Bilateral Renal Lymphadenectomy

Published on: December 30, 2025

6

Targeting CD20 for B-cell Depletion in Autoimmune Kidney Disease: Next Generation.

Federico Yandian1, Sanjeev Sethi2, Fernando C Fervenza3

  • 1Department of Nephrology, Médica Uruguaya, Avda. 8 de Octubre 2492, Montevideo, Uruguay. fedeuru141@hotmail.com.

Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|September 8, 2025
PubMed
Summary

Anti-CD20 monoclonal antibodies show promise in nephrology for autoimmune diseases. Understanding their mechanisms and potential failures is key for effective precision medicine in kidney conditions.

More Related Videos

Isolation of Double Negative αβ T Cells from the Kidney
06:56

Isolation of Double Negative αβ T Cells from the Kidney

Published on: May 16, 2014

12.8K
Rapid Depletion of Renal Macrophages Using Human CD59/Intermedilysin Cell Ablation Tool
10:15

Rapid Depletion of Renal Macrophages Using Human CD59/Intermedilysin Cell Ablation Tool

Published on: May 9, 2025

612

Related Experiment Videos

Last Updated: Jan 6, 2026

Murine Bilateral Renal Lymphadenectomy
06:20

Murine Bilateral Renal Lymphadenectomy

Published on: December 30, 2025

6
Isolation of Double Negative αβ T Cells from the Kidney
06:56

Isolation of Double Negative αβ T Cells from the Kidney

Published on: May 16, 2014

12.8K
Rapid Depletion of Renal Macrophages Using Human CD59/Intermedilysin Cell Ablation Tool
10:15

Rapid Depletion of Renal Macrophages Using Human CD59/Intermedilysin Cell Ablation Tool

Published on: May 9, 2025

612

Area of Science:

  • Nephrology
  • Immunology
  • Pharmacology

Background:

  • Anti-CD20 monoclonal antibodies, initially for hematologic cancers, are increasingly used in nephrology.
  • These B-cell depletion therapies are explored for autoimmune glomerulopathies, with or without podocytopathy.

Purpose of the Study:

  • To provide a molecular and clinical overview of anti-CD20 monoclonal antibodies in nephrology.
  • To guide understanding of their function, failure mechanisms, and alternative strategies.
  • To highlight their role in precision therapy for glomerular diseases.

Main Methods:

  • Review of current literature on anti-CD20 monoclonal antibodies in nephrology.
  • Inclusion of pharmacokinetic and pharmacodynamic data.
  • Analysis of clinical efficacy and safety profiles.

Main Results:

  • Anti-CD20 antibodies demonstrate efficacy and favorable safety in nephrology.
  • Novel agents offer alternatives or adjuncts to corticosteroids.
  • Efficacy varies across conditions and treatment settings.

Conclusions:

  • A deep understanding of anti-CD20 antibody mechanisms is crucial for precision medicine.
  • Resistance and therapeutic failure necessitate alternative strategies.
  • These antibodies are evolving as monotherapy or part of multi-targeted approaches for glomerular diseases.